Navigation Links
Study examines liver transplantation after drug induced acute liver failure
Date:7/1/2009

percent) and antibiotics (6 percent). For the entire cohort of transplant recipients, median survival time was 14.4 years. One year estimated survival probabilities were 76 percent, 82 percent, 52 percent, 82 percent, and 79 percent for acetaminophen, antituberculosis, antiepileptics, antibiotics and others, respectively.

"Among the patients who had acute liver failure due to antiepileptics, one-year survival was only 27 percent in patients less than 18 years old compared to 75 percent in patients 18 years old or older," the authors report. Interestingly, these patients were least likely to be listed as status 1 and spent the most time waiting for an organ. Also, the warm and cold ischemia times were longest for this group of patients. "The relatively low survival probability persisted after controlling for these variables in multivariate analysis," the authors report. The reasons for the decreased survival in this group could not be elucidated based on the available data.

Examining the different demographic and clinical factors for each patient and donor, the researchers noted that, "elevated serum creatinine, being on life support, and drug-induced acute liver failure due to antiepileptics (at age less than 18) were found to be independent pretransplant predictors of poor survival."

Using the entire study population, the researchers developed a prognostic model which showed strong predictive ability.

An accompanying editorial by Paul B. Watkins of the Institute for Drug Safety at the Hamner Institutes of Health Sciences, Research Triangle, NC and Paul H. Hayashi of the University of North Carolina , commends the authors for adding valuable information about acute liver failure caused by drugs. In particular, "the identification of poorer outcome for children with anti-epileptic drug induced acute liver failure is intriguing and points out the need for more focused research on drug induced liver injury in pediatric populations
'/>"/>

Contact: Sean Wagner
medicalnews@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study Supports Wider Use of Statins
2. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment
3. The European Association for the Study of the Liver renews publishing partnership with Elsevier
4. Study to see if video games can boost thinking skills in elderly
5. GIE: Gastrointestinal Endoscopy June issue study highlights
6. Study shows 1 in 25 deaths worldwide attributable to alcohol
7. Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation
8. U-M study finds voice box can be preserved, even with the largest cancers
9. Clinical Study Data Indicates that Celliant Reduces Pain
10. Girls Overall Self-Worth Improves With Contact Lens Wear, Study Shows
11. New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ov.25/PRNewswire/-- MISSIONSkincare ®isproudt...Jude.AspartofGNC,sannualSt.Jude ThanksandGiving ca...re,s new SUPER-C(TM)LipBalm willbedonatedtoSt.Ju...kea$1,$5or$10donationatcheckoutatoneoftheir5,000+r...1millionforSt.Judeduringtheir2009 ThanksandGiving ...
(Date:11/25/2009)...mprovementShownforthe4thStraightYear ,, WASHI...ancerAlliance-Georgia(LCA-GA)issuedthe 4thAnnualRe...ogressbeingmadeagainstthislethaldiseaseinthestateo...,theonlynationalorganizationdedicatedexclusivelyto...skforlungcancer. ,, (Logo: http://www.newscom.c...
(Date:11/25/2009)...treat colorectal cancer also can reverse a rare st... therapy for the disease, researchers at Vanderbil...ntrier,s disease causes thickening of the stomach ..., as well as anemia and swelling in the feet and a...ed risk for gastric cancer. Previously, the only e...
(Date:11/25/2009)...aced under the skin kill tumor cells, study finds ...-- A cancer vaccine delivered in a fingernail-size... study reports. , The method uses polymer disks...h tumor-specific antigens and implanted under the ...rs. The Harvard University scientists who develope...
(Date:11/25/2009)... Nationwide Imaging Services, known as one...r diagnostic imaging equipment, now offering a tot...nancing options, service and installation with acq...l Technologies of California) , ...onwide Imaging Services is proud to announce its a...
Breaking Medicine News(10 mins):Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3
...inn., Nov. 20 Forward Expeditions LLC, Ely, Minn.... historic Victorinox North,Pole expedition to rais...sota-based nonprofit organization offering free pe...0 million families each,year through personal, pri...
...TON, Pa., Nov. 20 Environmental Tectonics Corpora...Medical Systems Division has contracted with the L...ement group located in Mt. Vernon, NY, for deliver...Good Samaritan Hospital - Suffern New York. LST ut...
..., Calif., Nov. 20 STAAR Surgical Company,(Nasdaq:...f leading ophthalmic,surgeons, CAST (Collamer(R) A... in a collaborative effort in evaluating the accom...ity to "accommodate," or,to adjust to see near and...
... BY SAN DIEGO HOSPICE AND THE INSTITUTE FOR PALLIA... WHAT: , San Diego Hospice and The Institute... for coping with grief and loss during the upcomin...e of yourself first and foremost. , , 2. Fin...
...D, Conn., Nov. 20 Families looking for an easy,fu...d-winning gift option this,holiday season. Kideos...ool for,teaching kids to dance and get fit. This D...rition and exercise, Kideosyncrasy,promotes health...
... I/ITSEC, The largest exhibition...cutting-edge medical simulations ranging from mass... prediction and management on December 1-4 at the ...on of simulation technology ever held, will featur...
Other Medicine News:Health News:Forward Expeditions to Promote CaringBridge(R) on Historic Victorinox North Pole '09 Expedition 2Health News:Forward Expeditions to Promote CaringBridge(R) on Historic Victorinox North Pole '09 Expedition 3Health News:Forward Expeditions to Promote CaringBridge(R) on Historic Victorinox North Pole '09 Expedition 4Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers 2Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers 3Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers 4Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 2Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 3Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 4Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 5Health News:Ten Tips for Coping with Grief and Loss During the Holidays 2Health News:Ten Tips for Coping with Grief and Loss During the Holidays 3Health News:Give Kids the Gift of Fun and Fitness This Holiday Season 2Health News:Medical Technology to be Highlighted at World's Largest Simulation Exhibition 2
(Date:11/25/2009)...wswire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),...overing,developingandcommercializingnoveldrugstotr...iscalyearendedSeptember30,2009.AtSeptember30,2009P...shortterminvestments. ,, PipelineUpdateand2009...,, InlateNovember2009,anindependentDataMonitori...
(Date:11/25/2009)...e/--BioTrendsResearchGroup,Inc.releasedWave1ofits ...ulti-phasesyndicatedmarketresearchprojecttrackingt...ctlaunchthroughthefirstsixmonthsofavailability.Eac...m75uniqueDermatologistsandqualitativeinformationfr...,obstaclestouse,typicalpatienttypes,productpercept...
(Date:11/25/2009)...ewswire-USNewswire/--RemediumTechnologiesInc.,acom...ebleeding,wonfirstprizeand$10,000intheMostPromisin...009,companyofficialsannouncetoday. ,, Selectedf...teampitchedtheirinventionattheGSCSecuritySummitcon...dium( www.remediumtechnologies.com )isdevelopingah...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Group B Strep Screening Guidelines Sparing Newborns 49294 1Group B Strep Screening Guidelines Sparing Newborns 49294 2Group B Strep Screening Guidelines Sparing Newborns 49294 3Renaissance America Tracks Trend on Loss of Retiree Benefits in New Whitepaper 49291 1Renaissance America Tracks Trend on Loss of Retiree Benefits in New Whitepaper 49291 2Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference 12680 1
...a,Pharmaceuticals, Inc., a privately-held biotechn...ment of novel therapeutics for cardiovascular and,... raised $60 million in a,preferred stock financing...la,s two lead antithrombotic clinical candidates, ...eloping as best-in-class compounds to,replace exis...
...ceuticals,Inc., announced today it has initiated a...asiliximab) for the treatment of noninfectious uve...inflammation of the eye. The,randomized, double-ma...afety and efficacy of Simulect as maintenance ther...l undergo tapering of concomitant,immunosuppressiv...
Other Medicine Technology:Portola Completes $60 Million Financing to Advance Its Therapeutic Programs 2Portola Completes $60 Million Financing to Advance Its Therapeutic Programs 3Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis 2
TME 66 S
TME 64 S
TME 60 S
...r individual indications. XCaliber covers a compre...novative composite plastic material, XCaliber is s...ter. This means it's easier to handle, easier to a...pre-assembled, packaged sterile, and ready to use ...
Medicine Products: